1.Safety Evaluation of Bilateral Same-day Intravitreal Injections of Bevacizumab
Kyu Hwan JANG ; Ja Young AHN ; Joon Hong SOHN ; Daniel Duck-Jin HWANG
Journal of the Korean Ophthalmological Society 2020;61(10):1164-1168
Purpose:
To evaluate the short-term ophthalmic side effects of bilateral same-day intravitreal bevacizumab injections.
Methods:
We retrospectively analyzed patients who underwent intravitreal bevacizumab injection in both eyes on the same day from January 2015 to June 2019. The patients were followed up at 1 day, 1 week, and 1 month after the injection.
Results:
A total of 281 patients (153 males and 128 females) and 562 eyes were included in the study, and 950 bilateral same-day intravitreal bevacizumab injections were performed. The mean age of patients was 58.87 ± 13.44 years. The most common cause of bilateral injection was that of complications due to diabetic retinopathy, which accounted for 66.3%, followed by age-related macular degeneration at 22.2%, retinal vein occlusion at 5.1%, and central serious chorioretinopathy at 2.1%. There were 0 cases of endophthalmitis after 950 injections, 13 cases of subconjunctival hemorrhage, and 17 patients with a temporary elevation of intraocular pressure. There were 11 patients with acute intraocular inflammation after bilateral injection, but none in both eyes. Patients with acute intraocular inflammation were followed up at short-term intervals until they improved. All patients showed complete improvement within 2 weeks after injection. Comparing the patients’ condition before and after injection, visual acuity improved (p < 0.001).
Conclusions
In terms of the frequency of short-term ophthalmic adverse events, bilateral same-day intravitreal bevacizumab injection is a safe procedure with fewer side effects and is more convenient for both the patient and the doctor.
2.Safety Evaluation of Bilateral Same-day Intravitreal Injections of Bevacizumab
Kyu Hwan JANG ; Ja Young AHN ; Joon Hong SOHN ; Daniel Duck-Jin HWANG
Journal of the Korean Ophthalmological Society 2020;61(10):1164-1168
Purpose:
To evaluate the short-term ophthalmic side effects of bilateral same-day intravitreal bevacizumab injections.
Methods:
We retrospectively analyzed patients who underwent intravitreal bevacizumab injection in both eyes on the same day from January 2015 to June 2019. The patients were followed up at 1 day, 1 week, and 1 month after the injection.
Results:
A total of 281 patients (153 males and 128 females) and 562 eyes were included in the study, and 950 bilateral same-day intravitreal bevacizumab injections were performed. The mean age of patients was 58.87 ± 13.44 years. The most common cause of bilateral injection was that of complications due to diabetic retinopathy, which accounted for 66.3%, followed by age-related macular degeneration at 22.2%, retinal vein occlusion at 5.1%, and central serious chorioretinopathy at 2.1%. There were 0 cases of endophthalmitis after 950 injections, 13 cases of subconjunctival hemorrhage, and 17 patients with a temporary elevation of intraocular pressure. There were 11 patients with acute intraocular inflammation after bilateral injection, but none in both eyes. Patients with acute intraocular inflammation were followed up at short-term intervals until they improved. All patients showed complete improvement within 2 weeks after injection. Comparing the patients’ condition before and after injection, visual acuity improved (p < 0.001).
Conclusions
In terms of the frequency of short-term ophthalmic adverse events, bilateral same-day intravitreal bevacizumab injection is a safe procedure with fewer side effects and is more convenient for both the patient and the doctor.
3.Implementation of a resident night float system in a surgery department in Korea for 6 months: electronic medical record-based big data analysis and medical staff survey
Hyeong Won YU ; June Young CHOI ; Young Suk PARK ; Hyung Sub PARK ; YoungRok CHOI ; Sang Hoon AHN ; Eunyoung KANG ; Heung Kwon OH ; Eun Kyu KIM ; Jai Young CHO ; Duck Woo KIM ; Do Joong PARK ; Yoo Seok YOON ; Sung Bum KANG ; Hyung Ho KIM ; Ho Seong HAN ; Taeseung LEE
Annals of Surgical Treatment and Research 2019;96(5):209-215
PURPOSE: To evaluate superiority of a night float (NF) system in comparison to a traditional night on-call (NO) system for surgical residents at a single institution in terms of efficacy, safety, and satisfaction. METHODS: A NF system was implemented from March to September 2017 and big data analysis from electronic medical records was performed for all patients admitted for surgery or contacted from the emergency room (ER). Parameters including vital signs, mortality, and morbidity rates, as well as promptness of response to ER calls, were compared against a comparable period (March to September 2016) during which a NO system was in effect. A survey was also performed for physicians and nurses who had experienced both systems. RESULTS: A total of 150,000 clinical data were analyzed. Under the NO and NF systems, a total of 3,900 and 3,726 patients were admitted for surgery. Mortality rates were similar but postoperative bleeding was significantly higher in the NO system (0.5% vs. 0.2%, P = 0.031). From the 1,462 and 1,354 patients under the NO and NF systems respectively, that required surgical consultation from the ER, the time to response was significantly shorter in the NF system (54.5 ± 70.7 minutes vs. 66.8 ± 83.8 minutes, P < 0.001). Both physicians (90.4%) and nurses (91.4%) agreed that the NF system was more beneficial. CONCLUSION: This is the first report of a NF system using big data analysis in Korea, and potential benefits of this new system were observed in both ward and ER patient management.
Electronic Health Records
;
Emergency Service, Hospital
;
Hemorrhage
;
Humans
;
Internship and Residency
;
Korea
;
Medical Staff
;
Mortality
;
Statistics as Topic
;
Vital Signs
4.The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA Nephropathy.
Ho Jun CHIN ; Hyun Jin CHO ; Tae Woo LEE ; Ki Young NA ; Kook Hwan OH ; Kwon Wook JOO ; Hyung Jin YOON ; Yon Su KIM ; Curie AHN ; Jin Suk HAN ; Suhnggwon KIM ; En Sil JEON ; Dong Chan JIN ; Yong Lim KIM ; Sun Hee PARK ; Chan Duck KIM ; Young Rim SONG ; Seong Gyun KIM ; Yoon Goo KIM ; Jung Eun LEE ; Yoon Kyu OH ; Chun Soo LIM ; Sang Koo LEE ; Dong Wan CHAE ; Won Yong CHO ; Hyoung Kyu KIM ; Sang Kyung JO
Journal of Korean Medical Science 2009;24(Suppl 1):S22-S29
Oxidative stress plays various roles in the development and progression of IgA nephropathy, while bilirubin is known as a potent antioxidant. We therefore hypothesized that serum bilirubin would be associated with renal prognosis in IgA nephropathy. The study subjects comprised 1,458 adult patients with primary IgA nephropathy in Korea. We grouped patients according to the following quartile levels of bilirubin: <0.4 mg/dL (Q1), 0.4-0.5 mg/dL (Q2), 0.6-0.7 mg/dL (Q3), and >0.8 mg/dL (Q4). The outcome data were obtained from the Korean Registry of end-stage renal disease (ESRD). Eighty patients (5.5%) contracted ESRD during a mean follow-up period of 44.9 months. The ESRD incidences were 10.7% in Q1, 8.2% in Q2, 2.8% in Q3, and 2.8% in Q4 (p<0.001). The relative risk of ESRD compared to that in Q1 was 0.307 (95% confidence interval [CI], 0.126-0.751) in Q3 and 0.315 (95% CI, 0.130-0.765) in Q4. The differences of ESRD incidence were greater in subgroups of males and of patients aged 35 yr or more, with serum albumin 4.0 g/dL or more, with normotension, with eGFR 60 mL/min/1.73 m2 or more, and with proteinuria less then 3+ by dipstick test. In conclusion, higher bilirubin level was negatively associated with ESRD incidence in IgA nephropathy.
Adult
;
Bilirubin/*blood
;
Disease Progression
;
Female
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA/*blood/complications
;
Humans
;
Hypertension/complications
;
Incidence
;
Kidney Failure, Chronic/*blood/complications
;
Male
;
Middle Aged
;
Risk
;
Risk Factors
;
Treatment Outcome
5.Childhood Acute Immune Thrombocytopenic Purpura in Korea: Multicenter Study of Korean Society of Pediatric Hematology/Oncology.
Eun Jin CHOI ; Sun Min LEE ; Kun Soo LEE ; Dae Chul JEONG ; Hack Ki KIM ; Heung Sik KIM ; Soon Kyum KIM ; Gwang Chul LEE ; Don Hee AHN ; Im Joo KANG ; Young Ho LEE ; Hee Young SHIN ; Hyo Seop AHN ; Hae Lim JEONG ; Hong Hoe KOO ; Moon Kyu KIM ; Hwang Min KIM ; Chuhl Joo LYU ; Chang Hyun YANG ; Jeong Ohk HA ; Jong Jin SEO ; Thad T GHIM ; Chee Gwan KIM ; Chul Joo JEONG ; Kyu Chu CHOI ; Kyung Ha YOO ; Eun Seon YOO ; Soon Yong LEE ; Sang Woo KIM ; Soon Ki KIM ; Hoon KOOK ; Tai Ju HWANG ; Pyung Han HWANG ; Kyung Duck PARK ; Hyun Jin PARK ; Kwang Nam KIM ; Ki Joong KIM
Korean Journal of Pediatric Hematology-Oncology 2003;10(1):14-21
PURPOSE: Childhood acute immune thrombocytopenic purpura (ITP) is a benign hematologic disease. Therapy does not affect the natural history of the illness. We evaluated the clinical and laboratory findings, treatment and prognosis of childhood acute ITP in Korea through a retrospective multicenter study. METHODS: We analyzed retrospectively the data of 1, 829 children with acute ITP through survey of 33 hospitals among 43 hospitals in Korea from Sep. 1992 to Aug. 2001. RESULTS: Male to female ratio was 1.3: 1 and the median age at the diagnosis of ITP was 2.9 (0.1 17) years. Median duration of follow up was 6 months. One hundred and forty nine cases of the total 1, 829 patients (8.1%) received no treatment. The initial median platelet count of the non-treated group was 42, 500/mm3. Among the 861 cases who were followed up over 6 months, 315 cases (36.6%) progressed into chronic ITP. Associated with this high rate of chronicity of childhood acute ITP patients in Korea, we must consider the fact that acute ITP patients with fast improvement in the first episode tend not to follow up. Considering that fact, the rate of chronicity becomes 17.2% of the 1, 829 acute ITP patients. The treated group used many kinds of treatment methods. Intravenous immunoglobulins (IVIG) with or without prednisolone (PD) (67.5%) were the most commonly used regimens. In the group treated with IVIG alone, the platelet count began to rise above 50, 000/mm3 at 2.6 days, 100, 000/mm3 at 3.7 days and 150, 000/mm3 at 4.9 days. Four hundred and twenty two cases of the 1, 686 (25.0%) cases followed up after first episode of ITP relapsed. The relapse rate was significantly higher in older patients and in girls than in younger patients and in boys (P< 0.05). The chronicity of ITP statistically increased with age (P< 0.05) and that was the only valuable factor. CONCLUSION: Despite the fact that childhood acute ITP is a pretty common disaese, there is no agreement on the best treatment method for this disease. The establishment of Korean treatment guideline of childhood acute ITP, based on an analysis of multicenters, seems to be needed.
Child
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Hematologic Diseases
;
Humans
;
Immunoglobulins, Intravenous
;
Korea*
;
Male
;
Natural History
;
Platelet Count
;
Prednisolone
;
Prognosis
;
Purpura, Thrombocytopenic, Idiopathic*
;
Recurrence
;
Retrospective Studies
6.Analysis of Clinical Features and Factors Predictive of Malignancy in Intraductal Papillary Mucinous Tumor of the Pancreas: Multi-center Analysis in Korea.
Jin Young JANG ; Sun Whe KIM ; Young Joon AHN ; Yoo Seok YOON ; Kuhn Uk LEE ; Young Joo LEE ; Song Chul KIM ; Gee Hun KIM ; Duck Jong HAN ; Yong Il KIM ; Seong Ho CHOI ; Baik Hwan CHO ; Hee Chul YU ; Byong Ro KIM ; Dong Sup YOON ; Woo Jung LEE ; Kyung Bum LEE ; Young Chul KIM ; Kwang Soo LEE ; Kyeong Geun LEE ; Young Kook YUN ; Soon Chan HONG ; Koo Jeong KANG ; Tae Jin LIM ; Kyong Woo CHOI ; Yong Oon YOO ; Jong Hun PARK ; Young Hoon KIM ; Mun Sup SIM ; Hyung Chul KIM ; Chang Ho KIM ; Man Kyu CHAE ; Hong Yong KIM ; Young Gil CHOI ; Wook Hwan KIM ; Myung Wook KIM ; Hong Jin KIM ; Kwon Mook CHAE ; Dong Wook CHOI ; Sang Beom KIM ; Ho Seong HAN ; Seung Ik AHN ; Kuk Hwan KWON ; Chul Gyun JO ; Hyun Jong KIM ; Jae Woon CHOI ; Jong Riul LEE ; Joo Seop KIM ; Yong Hyun PARK
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2003;7(1):1-11
BACKGROUND/AIMS: Despite of increasing numbers of reports on intraductal papillary mucinous tumor (IPMT), there is still difficulty in its' diagnosis, treatment and prediction of prognosis. The purpose of this multicenter study was to evaluate the clinico-pathological features of IPMT in Korea and suggest the prediction criteria of malignancy in IPMT. METHODS: We retrospectively reviewed the clinico-pathological data of 208 patients who underwent operations with IPMT between 1993 and 2002 at 28 institutes in Korea. RESULTS: Of the 208 patients with a mean age of 60.5+/-9.7 years, 147 were men and 61 were women. 124 patients underwent pancreatoduodenectomy, 42 distal pancreatectomy, 17 total pancreatectomy, 25 limited pancreas resection. Benign cases were 128 (adenoma (n=62), borderline (n=66)) and malignant cases were 80 (non-invasive (n=29), invasive (n=51)). A significant difference in 5-year survival was observed between benign and malignant group (92.6% vs. 65.3%; p=0.006). Of the 6 factors (age, location, duct dilatation, tumor appearance, main duct type, and tumor size) that showed the statistical difference in univariate analysis between benign and malignant group, we found three significant factors (tumor appearance (p=0.009), tumor size (p=0.023), and dilated duct size (p=0.010)) by multivariate analysis. CONCLUSION: Although overall prognosis of IPMT is superior to ordinary pancreatic cancer, more curative surgery is recommended in malignant IPMT. Tumor appearance (papillary), tumor size (> or =30 mm) and dilated duct size (> or = 12 mm) can be used as preoperative indicators of malig-nancy in IPMT.
Academies and Institutes
;
Diagnosis
;
Dilatation
;
Female
;
Humans
;
Korea*
;
Male
;
Mucins*
;
Multivariate Analysis
;
Pancreas*
;
Pancreatectomy
;
Pancreatic Neoplasms
;
Pancreaticoduodenectomy
;
Prognosis
;
Retrospective Studies
7.Follow-up Study of Carpal Tunnel Syndrome with Conduction Block: Comparison between Operative and Non-operative Management.
Hee Kyu KWON ; Hang Jae LEE ; Ki Hyung KIM ; Duck Sun AHN
Journal of the Korean Academy of Rehabilitation Medicine 2003;27(3):369-373
OBJECTIVE: To compare the degree of improvement of conduction block in carpal tunnel syndrome (CTS) between the patients who received operation and those who received conservative treatment. METHOD: Subjects included 33 hands of 27 CTS patients who received operation (operation group) and 20 hands of 17 patients who were managed conservatively (non-operation group). Median antidromic sensory responses were recorded with wrist and palm stimulation. The criterion for conduction block was more than 50% drop of baseline to negative peak amplitude of sensory nerve action potential with wrist stimulation compared to palm stimulation. The degree of conduction block was measured before and aftertreatment, and the improvement of conduction block was compared between the two groups. RESULTS: The degrees of conduction block were 59.9+/-14.3% in operation group and 60.5+/-14.5% in the non-operation group at initial evaluation. The improvements of conduction block were 32.1+/-15.1% (5~58.9%) in operation group and 7.8+/-19.8% (-27.3~36.7%) in non-operation group after treatment and the difference was statistically significant. CONCLUSION: The results suggest that operative treatment may be useful even in patients with carpal tunnel syndrome with conduction block.
Action Potentials
;
Carpal Tunnel Syndrome*
;
Follow-Up Studies*
;
Hand
;
Humans
;
Wrist
8.The Effect of Antibody and Gene Therapy for Transforming Growth Factor- 1 on Scar Formation.
Jun Hyung KIM ; Ki Hwan HAN ; Jong Duck AHN ; In Kyu LEE ; Eun Joo KIM ; Mee Yul HWANG ; Kwan Kyu PARK
Korean Journal of Pathology 2001;35(5):424-432
BACKGROUND: Transforming growth factor (TGF)- has a large variety of biological functions, including the modulation of inflammation and the immune system, and is presumed to play important roles in repairing wounds and reducing scarring. The objective of this study is to examine the effects of TGF-1 on healing wounds and reducing scarring. We have also analysed the ability of the hemagglutinating virus of Japan (HVJ) liposome mediated antisense oligodeoxynucleotides (ODNs) to specifically inhibit wound-induced expressions of TGF-1 proteins and mRNA in the rat skin. METHODS: Skin wounds were created on the backs of 80 anesthetized rats. The first group of wounds, as the controls, was unmanipulated. The second group of wounds, as positive controls or an excessive scarring model, was injected with TGF-1 subcutaneously. The third group of wounds was injected with anti-TGF-1 antibody subcutaneously. The fourth group of wounds was injected with HVJ liposome mediated antisense ODNs for TGF-1 subcutaneously. The wounds of all groups were bisected and analysed histologically 5, 10, 15, 30, and 50 days after the wounds were made. RESULTS: All control wounds (TGF-1 or no injection) healed with scarring, whereas the wounds treated with the antibody or antisense ODNs healed with less scar formation compared to the control group. The wounds treated with the antibody or antisense ODNs had fewer macrophages, less collagen and fibronectin contents than the other wounds. Northern blotting and in situ hybridization analysis showed that wound sites treated with HVJ liposome mediated antisense ODNs for TGF-1 exhibited decreased levels of TGF-1 mRNA after injury. CONCLUSIONS: These findings suggest an important new approach to controlling scarring in normal wound healing, complementing the practice of adding exogenous growth factors to chronic wounds in the attempt to inhibit collagen deposition.
Animals
;
Blotting, Northern
;
Cicatrix*
;
Collagen
;
Complement System Proteins
;
Fibronectins
;
Genetic Therapy*
;
Immune System
;
In Situ Hybridization
;
Inflammation
;
Intercellular Signaling Peptides and Proteins
;
Liposomes
;
Macrophages
;
Oligodeoxyribonucleotides
;
Oligoribonucleotides
;
Rats
;
RNA, Messenger
;
Sendai virus
;
Skin
;
Transforming Growth Factor beta
;
Transforming Growth Factors
;
Wound Healing
;
Wounds and Injuries
9.Immortalization of human embryonic fibroblasts by overexpression of c-myc and simian virus 40 large T antigen.
Hyun Seok KIM ; Jong Yeon SHIN ; Ji Yeon YUN ; Duck Kyu AHN ; Jae Yong LEE
Experimental & Molecular Medicine 2001;33(4):293-298
SV40 large T antigen, a viral oncoprotein, is known to immortalize human diploid fibroblast by soaking up cellular RB and p53, but its frequency is extremely low. Additional genetic alteration is necessary for single-step immortalization. We attempted to find out what this alteration is by overexpressing cellular signal mediator genes; c-myc and cyclin D frequently amplified in many cancer cells. Overexpression of cyclin D did not affect the immortalization, but, overexpression of c-myc along with T antigen could immortalize normal human diploid fibroblast. Several cellular markers tested during immortalization process showed that p21, a cyclin-dependent kinase inhibitor and a marker of cellular senescence, disappeared in the life span-extended cells by T antigen and in the immortalized cells by c-myc. p21 was, however, elevated in the senescent cells and in the cells of crisis. Interestingly, p16 was upregulated whenever T antigen is overexpressed. Telomerase activity was also activated only in the immortalized cells. These results suggest that overexpression of c-myc contributes to immortalization of human diploid fibroblast by activating telomerase activity and suppressing p21 activity.
Antigens, Polyomavirus Transforming/genetics/*metabolism
;
Biological Markers
;
Cell Aging/*genetics
;
Cell Transformation, Viral
;
Cells, Cultured
;
Cyclins/metabolism
;
Diploidy
;
Fibroblasts/*metabolism
;
Genes, myc/*genetics
;
Human
;
Protein p16/metabolism
;
Simian virus 40/genetics
;
Support, Non-U.S. Gov't
;
Telomerase/metabolism
10.Immortalization of human embryonic fibroblasts by overexpression of c-myc and simian virus 40 large T antigen.
Hyun Seok KIM ; Jong Yeon SHIN ; Ji Yeon YUN ; Duck Kyu AHN ; Jae Yong LEE
Experimental & Molecular Medicine 2001;33(4):293-298
SV40 large T antigen, a viral oncoprotein, is known to immortalize human diploid fibroblast by soaking up cellular RB and p53, but its frequency is extremely low. Additional genetic alteration is necessary for single-step immortalization. We attempted to find out what this alteration is by overexpressing cellular signal mediator genes; c-myc and cyclin D frequently amplified in many cancer cells. Overexpression of cyclin D did not affect the immortalization, but, overexpression of c-myc along with T antigen could immortalize normal human diploid fibroblast. Several cellular markers tested during immortalization process showed that p21, a cyclin-dependent kinase inhibitor and a marker of cellular senescence, disappeared in the life span-extended cells by T antigen and in the immortalized cells by c-myc. p21 was, however, elevated in the senescent cells and in the cells of crisis. Interestingly, p16 was upregulated whenever T antigen is overexpressed. Telomerase activity was also activated only in the immortalized cells. These results suggest that overexpression of c-myc contributes to immortalization of human diploid fibroblast by activating telomerase activity and suppressing p21 activity.
Antigens, Polyomavirus Transforming/genetics/*metabolism
;
Biological Markers
;
Cell Aging/*genetics
;
Cell Transformation, Viral
;
Cells, Cultured
;
Cyclins/metabolism
;
Diploidy
;
Fibroblasts/*metabolism
;
Genes, myc/*genetics
;
Human
;
Protein p16/metabolism
;
Simian virus 40/genetics
;
Support, Non-U.S. Gov't
;
Telomerase/metabolism

Result Analysis
Print
Save
E-mail